That is the difference between information and results
Cellular senescence: "Zombie cells" that secrete inflammatory factors, promoting further aging
(2024) confirmed dose-dependent body-weight and fat-mass reduction over a longer treatment window, with improvements in fatty-liver markers
Our team assesses biomarkers, goals, and designs protocolsNAD+ via injections/IVs, 5-Amino-1MQ as capsules/injections
What is the difference between protocols and stacks
We update protocols when new clinical trial data publishes (for example, when TRIUMPH Phase 3 readouts update the retatrutide protocol), when regulatory status changes (the February 2026 FDA Category 2 reclassification affected multiple compound pages), or when reconstitution math needs correction